Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Shinozaki, Youichi ^a,b   Nomura, Masatoshi ^c   Iwatsuki, Ken ^d   Moriyama, Yoshinori ^e   Gachet, Christian ^f   Koizumi, Schuichi ^a,b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d AJINOMOTO CO INC   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; INTERLEUKIN 6; METHYLMERCURY DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEOTIDE TRANSPORTER; PURINERGIC P2Y1 RECEPTOR;

ANIMAL; ASTROCYTE; BIOSYNTHESIS; CALCIUM SIGNALING; CELL COMMUNICATION; CELL CULTURE; DRUG EFFECTS; EXOCYTOSIS; GENETICS; HIPPOCAMPUS; KNOCKOUT MOUSE; METABOLISM; MICROGLIA; MOUSE; NERVE CELL; RAT; SYNAPTIC TRANSMISSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASTROCYTES; CALCIUM SIGNALING; CELL COMMUNICATION; CELLS, CULTURED; EXOCYTOSIS; HIPPOCAMPUS; INTERLEUKIN-6; METHYLMERCURY COMPOUNDS; MICE; MICE, KNOCKOUT; MICROGLIA; NEURONS; NUCLEOTIDE TRANSPORT PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RECEPTORS, PURINERGIC P2Y1; SYNAPTIC TRANSMISSION;

EID: 84913599974     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04329     Document Type: Article

References (60)

1. Tremblay, M. E. et al. The role of microglia in the healthy brain. J Neurosci 31, 16064-16069 (2011).
2. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318 (2005).
3. Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752-758 (2005).
4. Ouchi, Y. et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57, 168-175 (2005).
5. Kingwell, K. Neurodegenerative disease: Microglia in early disease stages. Nat Rev Neurol 8, 475 (2012).
6. Kettenmann, H., Hanisch, U. K., Noda, M. & Verkhratsky, A. Physiology of microglia. Physiol Rev 91, 461-553 (2011).
7. Koizumi, S. et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446, 1091-1095 (2007).
8. Haynes, S. E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9, 1512-1519 (2006).
9. Chekeni, F. B. et al . Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 467, 863-867 (2010).
10. Liu, G. J., Kalous, A., Werry, E. L. & Bennett, M. R. Purine release from spinal cord microglia after elevation of calcium by glutamate. Mol Pharmacol 70, 851-859 (2006).
11. Imura, Y. et al. Microglia release ATP by exocytosis. Glia 61, 1320-1330 (2013).
12. Dou, Y. et al. Microglial migration mediated by ATP-induced ATP release from lysosomes. Cell Res 22, 1022-1033 (2012).
13. Pascual, O., Ben Achour, S., Rostaing, P., Triller, A. & Bessis, A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci U S A 109, E197-205 (2012).
14. Fujita, T., Tozaki-Saitoh, H. & Inoue, K. P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia 57, 244-257 (2009).
15. Zheng, W. et al. Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS One 5, e14401 (2010).
16. Talley Watts, L. et al. Purinergic 2Y1 receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model. J Neurotrauma 30, 55-66 (2013).
17. Noguchi, Y. et al. Astrocytes protect neurons against methylmercury via ATP/P2Y(1) receptor-mediated pathways in astrocytes. PLoS One 8, e57898 (2013).
18. Clarkson, T. W. The toxicology of mercury. Crit Rev Clin Lab Sci 34, 369-403 (1997).
19. Lapham, L. W. et al. An analysis of autopsy brain tissue from infants prenatally exposed to methymercury. Neurotoxicology 16, 689-704 (1995).
20. Clarkson, T. W., Magos, L. & Myers, G. J. The toxicology of mercury - current exposures and clinical manifestations. N Engl J Med 349, 1731-1737 (2003).
21. Monnet-Tschudi, F., Zurich, M. G. & Honegger, P. Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Res 741, 52-59 (1996).
22. Charleston, J. S. et al. Increases in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methyl mercury exposure. Toxicol Appl Pharmacol 129, 196-206 (1994).
23. Ueno, M. et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci 16, 543-551 (2013).
24. Vinet, J. et al. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflammation 9, 27 (2012).
25. Imai, H. et al. Development of a fast method for quantitative measurement of hyperpolarized 129Xe dynamics in mouse brain. NMR Biomed 25, 210-217 (2012).
26. Leon, C. et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104, 1731-1737 (1999).
27. Shinozaki, Y. et al. Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y1 receptors. Glia 49, 288-300 (2005).
28. Koizumi, S., Fujishita, K., Tsuda, M., Shigemoto-Mogami, Y.&Inoue, K. Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc Natl Acad Sci U S A 100, 11023-11028 (2003).
29. Shinozaki, Y. et al. Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase. Neuroscience 147, 153-163 (2007).
30. Gogolla, N., Galimberti, I., DePaola, V. & Caroni, P. Preparation of organotypic hippocampal slice cultures for long-term live imaging. Nat Protoc 1, 1165-1171 (2006).
31. Eskes, C., Honegger, P., Juillerat-Jeanneret, L. & Monnet-Tschudi, F. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 37, 43-52 (2002).
32. Tikka, T., Fiebich, B. L., Goldsteins, G., Keinanen, R.&Koistinaho, J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21, 2580-2588 (2001).
33. Nishioku, T. et al. Involvement of caspase 3-like protease in methylmercury-induced apoptosis of primary cultured rat cerebral microglia. Brain Res 871, 160-164 (2000).
34. Tiernan, C. T., Edwin, E. A., Goudreau, J. L., Atchison, W. D. & Lookingland, K. J. The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells. Toxicol Sci 133, 125-132 (2013).
35. Graevskaya, E. E., Yasutake, A., Aramaki, R. & Rubin, A. B. Effect of methylmercury on histamine release from rat mast cells. Arch Toxicol 77, 17-21 (2003).
36. Blasi, J. et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365, 160-163 (1993).
37. Binz, T. et al. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 269, 1617-1620 (1994).
38. Macklis, J. D. &Madison, R. D. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity. J Neurosci Methods 31, 43-46 (1990).
39. Tai, Y. F. et al.Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 130, 1759-1766 (2007).
40. Sanagi, T. et al. Involvement of activated microglia in increased vulnerability of motoneurons after facial nerve avulsion in presymptomatic amyotrophic lateral sclerosis model rats. Glia 60, 782-793 (2012).
41. Neumann, J. et al.Microglia provide neuroprotection after ischemia. FASEB J 20, 714-716 (2006).
42. Mitrasinovic, O. M. et al. Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system. J Neurosci 25, 4442-4451 (2005).
43. Shigemoto-Mogami, Y. et al. Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem 78, 1339-1349 (2001).
44. Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87, 659-797 (2007).
45. Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S. & Inoue, K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89-95 (2004).
46. Jin, S. X., Zhuang, Z. Y., Woolf, C. J. & Ji, R. R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23, 4017-4022 (2003).
47. Ehrenfeld, P. et al. Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family. J Leukoc Biol 86, 1179-1189 (2009).
48. Meshki, J., Tuluc, F., Bredetean, O., Ding, Z. & Kunapuli, S. P. Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. Am J Physiol Cell Physiol 286, C264-271 (2004).
49. Yee, S. & Choi, B. H. Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology 17, 17-26 (1996).
50. Mundy, W. R. & Freudenrich, T. M. Sensitivity of immature neurons in culture to metal-induced changes in reactive oxygen species and intracellular free calcium. Neurotoxicology 21, 1135-1144 (2000).
51. Gasso, S. et al. Antioxidant compounds and Ca(2+) pathway blockers differentially protect against methylmercury and mercuric chloride neurotoxicity. J Neurosci Res 66, 135-145 (2001).
52. Ali, S. F., LeBel, C. P. & Bondy, S. C. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 13, 637-648 (1992).
53. Ni, M. et al. Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. Toxicol Sci 116, 590-603 (2010).
54. Zhuang, S., Demirs, J. T. & Kochevar, I. E. p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J Biol Chem 275, 25939-25948 (2000).
55. Kurata, S. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J Biol Chem 275, 23413-23416 (2000).
56. Ushio-Fukai, M., Alexander, R. W., Akers, M. & Griendling, K. K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273, 15022-15029 (1998).
57. Qin, L. et al. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 52, 78-84 (2005).
58. Block, M. L., Zecca, L.&Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8, 57-69 (2007).
59. Biber, K. et al. Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 33, 2237-2250 (2008).
60. Biber, K., Lubrich, B., Fiebich, B. L., Boddeke, H. W. & van Calker, D. Interleukin-6 enhances expression of adenosine A(1) receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices. Neuropsychopharmacology 24, 86-96 (2001).